Industry News
Pharmaceutical Industry News
Despite strong efficacy, dermatologist survey indicates Incyte’s Opzelura uptake may face uphill climb: report
Despite strong efficacy, dermatologist survey indicates Incyte's Opzelura uptake may face uphill climb: report kdunleavy Thu, 11/11/2021 - 11:37
Lundbeck cuts 300 jobs to fuel Vyepti growth as CGRP migraine competition heats up
Lundbeck cuts 300 jobs to fuel Vyepti growth as CGRP migraine competition heats up aliu Thu, 11/11/2021 - 10:20
Baxter CDMO arm to drop $100M to expand fill-finish plant in Germany
Baxter CDMO arm to drop $100M to expand fill-finish plant in Germany jkeenan Thu, 11/11/2021 - 09:53
Novartis-backed Gamida’s approval plans for cell therapy hits a snag with FDA asking for manufacturing data
Novartis-backed Gamida's approval plans for cell therapy hits a snag with FDA asking for manufacturing data jkeenan Thu, 11/11/2021 - 09:22
EMA flags Johnson & Johnson COVID vaccine for rare disorder, passes mRNA shots for one side effect but probes another
EMA flags Johnson & Johnson COVID vaccine for rare disorder, passes mRNA shots for one side effect but probes another kdunleavy Thu, 11/11/2021 - 09:22
Seres Therapeutics taps Bacthera to manufacture its lead microbiome therapy at Lonza’s Swiss campus
Seres Therapeutics taps Bacthera to manufacture its lead microbiome therapy at Lonza's Swiss campus jkeenan Thu, 11/11/2021 - 08:19
Johnson & Johnson scores 60-day stay in high-profile talc litigation: report
Johnson & Johnson scores 60-day stay in high-profile talc litigation: report esagonowsky Wed, 11/10/2021 - 15:32
Antony Blinken Says ‘We Have Fallen Short’ on Global Vaccine Distribution
The Secretary of State called for rich countries, pharmaceutical companies and others to “step up.”
Eli Lilly touts long-term safety data for Olumiant amid classwide scrutiny on JAK meds
Eli Lilly touts long-term safety data for Olumiant amid classwide scrutiny on JAK meds aliu Wed, 11/10/2021 - 11:30
Merck inks yet another $1B-plus supply deal for COVID pill, this time with Japan
Merck inks yet another $1B-plus supply deal for COVID pill, this time with Japan esagonowsky Wed, 11/10/2021 - 11:01
Moderna, U.S. clash in patent dispute over origins of COVID-19 vaccine: report
Moderna, U.S. clash in patent dispute over origins of COVID-19 vaccine: report kdunleavy Wed, 11/10/2021 - 10:56
AstraZeneca, FibroGen hope to keep their roxadustat dream alive with new FDA meeting
AstraZeneca, FibroGen hope to keep their roxadustat dream alive with new FDA meeting aliu Wed, 11/10/2021 - 09:40
Oklahoma Supreme Court Throws Out $465 Million Opioid Ruling Against J.&J.
The 5-1 decision is a setback for those who are fighting to hold big drug makers accountable for the opioid epidemic.
Moderna and U.S. at Odds Over Vaccine Patent Rights
Moderna’s patent application names several employees as the sole inventors of a crucial component of its coronavirus vaccine, excluding three government scientists.
AstraZeneca creates unit to handle its COVID-19 vaccines and antibody treatments
AstraZeneca creates unit to handle its COVID-19 vaccines and antibody treatments kdunleavy Tue, 11/09/2021 - 15:40
AstraZeneca creates unit to handle its COVID-19 vaccines, antibody treatments
AstraZeneca creates unit to handle its COVID-19 vaccines, antibody treatments kdunleavy Tue, 11/09/2021 - 15:40
Johnson & Johnson scores reversal of landmark $465M opioid ruling in Oklahoma
Johnson & Johnson scores reversal of landmark $465M opioid ruling in Oklahoma esagonowsky Tue, 11/09/2021 - 14:27
Regeneron and Novo Nordisk hold tight at the top spots on October list of biggest TV ad spenders
Regeneron and Novo Nordisk hold tight at the top spots on October list of biggest TV ad spenders sharon.coey Tue, 11/09/2021 - 12:25
Biogen’s Aduhelm records one patient death. Is the controversial Alzheimer’s drug to blame?
Biogen's Aduhelm records one patient death. Is the controversial Alzheimer’s drug to blame? aliu Tue, 11/09/2021 - 11:35
As BioNTech raises expected COVID-19 vaccine sales to $19.6B, CEO stumps for wider booster use
As BioNTech raises expected COVID-19 vaccine sales to $19.6B, CEO stumps for wider booster use kdunleavy Tue, 11/09/2021 - 11:21